BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18056893)

  • 21. Low hemoglobin A1c and low body mass index are associated with dementia and activities of daily living disability among Japanese nursing home residents with diabetes.
    Hatano Y; Araki A; Matsumoto M; Ishibashi S
    Geriatr Gerontol Int; 2019 Sep; 19(9):854-860. PubMed ID: 31257696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
    Abbatecola AM; Bo M; Armellini F; D'Amico F; Desideri G; Falaschi P; Greco A; Guerrini G; Lattanzio F; Volpe C; Paolisso G
    Metabolism; 2015 Nov; 64(11):1500-6. PubMed ID: 26318195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.
    Blicklé JF; Hancu N; Piletic M; Profozic V; Shestakova M; Dain MP; Jacqueminet S; Grimaldi A
    Diabetes Obes Metab; 2009 Apr; 11(4):379-86. PubMed ID: 19087105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus.
    Alonso-Fernández M; Mancera-Romero J; Mediavilla-Bravo JJ; Comas-Samper JM; López-Simarro F; Pérez-Unanua MP; Iturralde-Iriso J;
    Prim Care Diabetes; 2015 Oct; 9(5):385-91. PubMed ID: 25686480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.
    Munshi MN; Slyne C; Segal AR; Saul N; Lyons C; Weinger K
    J Diabetes Complications; 2017 Jul; 31(7):1197-1199. PubMed ID: 28343792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin].
    Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
    Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S27-38. PubMed ID: 23529568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020.
    McCoy RG; Galindo RJ; Swarna KS; Van Houten HK; O'Connor PJ; Umpierrez GE; Shah ND
    JAMA Netw Open; 2021 Sep; 4(9):e2123471. PubMed ID: 34468753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the relationship between type 2 diabetes mellitus and falls in older adults: a prospective cohort study.
    Roman de Mettelinge T; Cambier D; Calders P; Van Den Noortgate N; Delbaere K
    PLoS One; 2013; 8(6):e67055. PubMed ID: 23825617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
    Turner R; Cull C; Holman R
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic control with preprandial versus basal insulin in patients with type 2 diabetes mellitus poorly controlled by oral antidiabetes agents.
    Heise T; Mathieu C; Hey-Hadavi J; Strack T; Lawrence D
    Diabetes Technol Ther; 2010 Feb; 12(2):135-41. PubMed ID: 20105043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
    Rosenstock J; Eliaschewitz FG; Heilmann CR; Muchmore DB; Hayes RP; Belin RM
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S63-73. PubMed ID: 19772451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes.
    Jovanovič L; Peters AL; Jiang HH; Hardin DS
    Aging Clin Exp Res; 2014 Apr; 26(2):115-21. PubMed ID: 24092662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.